TipRanks
Lakefront Biotherapeutics (DE:GXEA)
FRANKFURT:GXEA
Germany Market
GXEA
Lakefront Biotherapeutics
RESEARCH TOOLSreports

Lakefront Biotherapeutics (GXEA) Income Statement

0 Followers

Lakefront Biotherapeutics Income Statement

Last quarter (Q2 2026), Lakefront Biotherapeutics's total revenue was €12.12M, a decrease of -81.44% from the same quarter last year. In Q2, Lakefront Biotherapeutics's net income was €2.11M. See Lakefront Biotherapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
€ 1.11B€ 275.65M€ 239.72M€ 241.25M€ 484.85M
Gross Profit
€ 1.08B€ 240.79M€ 239.72M€ 241.25M€ 483.22M
Operating Expenses
€ 581.12M€ 429.12M€ 327.99M€ 372.31M€ 648.81M
Depreciation and Amortization
€ 55.88M€ 45.50M€ 43.64M€ 65.57M€ 21.30M
EBITDA
€ 358.96M€ 43.33M€ 51.04M€ 3.87M€ -100.93M
Operating Income
€ 501.39M€ -188.34M€ -88.26M€ -131.06M€ -165.60M
Other Income/Expenses
€ -200.52M€ 185.25M€ 93.89M€ 60.21M€ 48.57M
Pretax Income
€ 300.87M€ -3.08M€ 5.63M€ -70.85M€ -123.00M
Net Income
€ 320.88M€ 74.08M€ 211.70M€ -217.99M€ -125.42M
Per Share Metrics
Basic EPS
€ 4.87€ 1.12€ -0.06€ -3.32€ -1.91
Diluted EPS
€ 4.87€ 1.12€ -0.06€ -3.32€ -1.91
Weighted Average Shares Outstanding
 65.90M 66.14M 65.93M 65.70M 65.50M
Weighted Average Shares Outstanding (Diluted)
 65.90M 66.14M 65.93M 65.70M 65.50M
Currency in EUR

Lakefront Biotherapeutics Earnings and Revenue History